Johnson & Johnson
FollowJohnson & Johnson Archives
Johnson & Johnson ordered to pay US$8 billion over Risperdal side effects
Plaintiff claims J&J's antipsychotic drug Risperdal can cause abnormal growth of female breast tissue in boys.
Johnson & Johnson cans CMO role as Alison Lewis departs
The consumer goods giant is streamlining priorities under a new business model.
J&J ordered to pay US$29m in talc trial
Latest defeat for the healthcare conglomerate which is facing over 13,000 similar lawsuits nationwide.
J&J forecasts sales to slow in 2019
The healthcare conglomerate beat expectations for the fourth quarter of 2018.
Latest J&J talc trial underway
Plaintiff alleges J&J talc product caused mesothelioma.
J&J CEO responds to asbestos report
Consumer goods company moves to reassure consumers that its products are safe.
J&J knew about asbestos in its baby powder for decades
The company withheld the information from regulators and the public.
J&J extends QUT collaboration
The three year extension will allow for continued life-science innovative research.
Johnson & Johnson addresses plastic waste problem
FMCG giant signs New Plastics Economy Global Commitment.
Johnson & Johnson sells LifeScan for $2.1bn
FMCG giant will still continue to create products for consumers with diabetes.
This week in FMCG
What happened this week in Australia's fast moving consumer goods sector?
Johnson & Johnson receives $2 billion offer to acquire LifeScan, Inc.
LifeScan manufactures blood glucose monitoring products.
Johnson & Johnson tops forecasts
Healthcare company Johnson & Johnson profit surpasses Wall Street expectations.
Johnson & Johnson surpasses Q1 forecasts
Johnson & Johnson beats analyst's forecast for the first quarter.
NZ watchdog rejects lubricants merger
Commerce Commission rules out Reckitt Benckiser's proposal to purchase Johnson & Johnson’s K-Y brand.